$15.60
-0.20-1.27%
At close: -
$24.66
9.0658.08%
After Hours: Jan 2, 5:29 PM EDT
Forte Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Forte Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-4.54 | $-7.12 | 36.2 % |
Q2 | 2024-08-14 | $-6.75 | $-4.25 | -58.8 % |
Q4 | 2023-03-31 | $-6.00 | $-4.00 | -50.0 % |
Q3 | 2022-11-14 | $-4.50 | $-3.75 | -20.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Forte Biosciences (FBRX) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-4.54, which beat the estimate of $-7.12.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.